BreviTest co-founder discusses technology that reduces diagnostic times

Share

Dr. Dev Chatterjee has developed an ultra–fast diagnostic device that can diagnose Ebola in the time it takes to brew coffee. Chatterjee, co-founder of BreviTest, takes a novel approach that re-imagines the immunoassay method as serial reactions in connected microfluidic chambers, which eliminates the traditional requirement of multiple washes to comprehensively remove residual reactants. BreviTest’s patent-pending technology has been reduced to practice with a prototype that successfully demonstrated completely automated ELISA reactions.

Speak Your Mind

*